Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Apr 2;10(1):5814.
doi: 10.1038/s41598-020-62795-1.

Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis

Affiliations
Meta-Analysis

Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis

Jorabar Singh Nirwan et al. Sci Rep. .

Abstract

Although gastro-oesophageal reflux disease (GORD) is a common medical complaint, there is currently no consensus on the global prevalence of GORD. The aim of this study was to conduct a systematic review and meta-analysis on GORD prevalence and risk factors at a global level. MEDLINE, EMBASE, CINAHL, Scopus, Cochrane library, and Google Scholar were systematically searched, without language restrictions, for studies on the prevalence and risk factors of GORD. Data were pooled using a random effects model (95% confidence interval), and the odds ratio and relative risk for each risk factor were calculated. Out of 34,355 search results, 96 records reporting the results from 102 studies fulfilled the inclusion criteria, representing 37 countries and all regions of the UN geoscheme. The global pooled prevalence of GORD was 13.98% and varied greatly according to region (12.88% in Latin America and the Caribbean to 19.55% in North America) and country (4.16% in China to 22.40% in Turkey). Using the United Nations 2017 Revision of World Population Prospects, the estimated number of individuals suffering from GORD globally is 1.03 billion. Multiple risk factors associated with a significant increase in the risk of GORD were also identified. This systematic review and meta-analysis revealed that although a substantial proportion (13.98%) of the global population suffers from GORD, there are significant variations between regions and countries. Risk factors for GORD were also identified which may allow clinicians to recognise individuals most at risk.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Flow-diagram of study selection.
Figure 2
Figure 2
Distribution of GORD prevalence according to country.
Figure 3
Figure 3
Distribution of GORD prevalence according to sub-regions (Northern America, South America, Northern Europe, Western Europe, Southern Europe, Eastern Europe, Western Africa, Western Asia, Southern Asia, Eastern Asia, South-eastern Asia, Australia & New Zealand).
Figure 4
Figure 4
Distribution of GORD prevalence according to global prevalence.

References

    1. Nwokediuko S. Current trends in the management of gastroesophageal reflux disease: a review. ISRN Gastroenterol. 2012;2012:1–11. doi: 10.5402/2012/391631. - DOI - PMC - PubMed
    1. Ofman J. The economic and quality-of-life impact of symptomatic gastroesophageal reflux disease. Am. J. Gastroenterol. 2003;98:S8–S14. doi: 10.1016/S0002-9270(03)00010-8. - DOI - PubMed
    1. Lee YY, McColl KE. Pathophysiology of gastroesophageal reflux disease. Best. Pract. Res. Clin. Gastroenterol. 2013;27:339–351. doi: 10.1016/j.bpg.2013.06.002. - DOI - PubMed
    1. Miller L, et al. The esophagogastric junction. Ann. N. Y. Acad. Sci. 2011;1232:323–330. doi: 10.1111/j.1749-6632.2011.06073.x. - DOI - PMC - PubMed
    1. Orlando RC. Overview of the mechanisms of gastroesophageal reflux. Am. J. Med. 2001;111:174–177. doi: 10.1016/S0002-9343(01)00828-2. - DOI - PubMed

Publication types